Cleared Traditional

K112755 - ABACUS 5

K112755 is an FDA 510(k) clearance for ABACUS 5, manufactured by Diatron U.S., Inc.. The device is a Class 2 Hematology device with product code GKZ cleared through the Traditional 510(k) pathway after a 188-day FDA review.

K112755 · Diatron U.S., Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2012
Decision
188d
Days
Class 2
Risk

K112755 is an FDA 510(k) clearance for the ABACUS 5. Classified as Counter, Differential Cell (product code GKZ), Class II - Special Controls.

Submitted by Diatron U.S., Inc. (Lenexa, US). The FDA issued a Cleared decision on March 27, 2012 after a review of 188 days - an extended review cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5220 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Diatron U.S., Inc. devices

FDA 510(k) Submission Details - K112755

510(k) Number K112755 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 21, 2011
Decision Date March 27, 2012
Days to Decision 188 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
75d slower than avg
Panel avg: 113d · This submission: 188d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GKZ Device Classification - Class 2, Special Controls

Product Code GKZ Counter, Differential Cell
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKZ Counter, Differential Cell

All 295
Devices cleared under the same product code (GKZ) and FDA review panel - the closest regulatory comparables to K112755.
UNICEL DXH 800 COULTER CELLULAR ANALYSIS SYSTEM
K120771 · Beckman Coulter, Inc. · Mar 2013
SYSMEX XN-SERIES
K112605 · Sysmex America, Inc. · Oct 2012
ABACUS 3CP
K111534 · Diatron U.S., Inc. · Aug 2012
CELL-DYN EMERALD 22 SYSTEM
K110381 · Abbott Laboratories · Dec 2011
ADVIA 2120 WITH AUTOSLIDE SYSTEM, AND ADVIA 2120I
K102644 · Siemens Healthcare Diagnostics · Nov 2011
BD FACS SAMPLE PREP ASSISTANT III (SPA III)
K102064 · Becton, Dickinson & CO · Mar 2011